Former Purdue Chairman Sought To Shadow Opioid Sales Reps, Massachusetts AG Suit Says
Executive Summary
Exec was worried Richard Sackler's visits could prompt complaints to FDA's Bad Ad Program; complaint alleges deceptive actions by Purdue execs to boost opioid prescriptions.
You may also be interested in...
Opioid Litigation Avalanche: New York's Expanded Suit Puts More Pressure On Makers And Distributors
Complaint claims Sackler family transferred opioid profits to personal trusts; trials scheduled in federal multidistrict litigation and several state cases.
Purdue's 'Landmark' Settlement With Oklahoma May Be Harbinger Of MDL Resolution
Company is paying nearly $200m for an Oklahoma State University endowment, $12.5m to abate effects of opioid crisis and $60m for litigation costs.
Keeping Track: Two Goal Date Extensions, Another Herceptin Biosimilar Approval, And A BLA Withdrawal
The latest drug development news and highlights from our US FDA Performance Tracker.